Genocea Biosciences (GNCA) Insider Trading & Ownership → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free GNCA Stock Alerts Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Genocea Biosciences (NASDAQ:GNCA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.61%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)7Amount OfInsider Selling(Last 3 Years)$791,721.35 Get GNCA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genocea Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GNCA Insider Buying and Selling by Quarter Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy Genocea Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/1/2022Jacquelyn L SumerInsiderSell2,500$0.06$150.00 5/31/2022William D ClarkCEOSell117,244$0.06$7,034.64 5/26/2022Diantha DuvallCFOSell24,407$0.08$1,952.56 5/25/2022Ali BehbahaniDirectorSell4,445,093$0.08$355,607.44 5/25/2022Jessica Baker FlechtnerInsiderSell16,525$0.09$1,487.25 5/24/2022Paul Edward WalkerMajor ShareholderSell5,931,843$0.07$415,229.01 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/4/2022Diantha DuvallCFOSell963$1.25$1,203.75 4/4/2022Jessica Baker FlechtnerInsiderSell1,212$1.25$1,515.00 4/4/2022William D ClarkCEOSell3,924$1.25$4,905.00 3/16/2022Girish N AakaluInsiderSell2,397$1.10$2,636.70 (Data available from 1/1/2013 forward) GNCA Insider Trading Activity - Frequently Asked Questions Who is on Genocea Biosciences's Insider Roster? The list of insiders at Genocea Biosciences includes Ali Behbahani, Diantha Duvall, Girish N Aakalu, Jacquelyn L Sumer, Jessica Baker Flechtner, Paul Edward Walker, and William D Clark. Learn more on insiders at GNCA. What percentage of Genocea Biosciences stock is owned by insiders? 1.61% of Genocea Biosciences stock is owned by insiders. Learn more on GNCA's insider holdings. Which Genocea Biosciences insiders have been selling company stock? The following insiders have sold GNCA shares in the last 24 months: Ali Behbahani ($355,607.44), Diantha Duvall ($3,156.31), Jacquelyn L Sumer ($150.00), Jessica Baker Flechtner ($3,002.25), Paul Edward Walker ($415,229.01), and William D Clark ($11,939.64). How much insider selling is happening at Genocea Biosciences? Insiders have sold a total of 10,543,711 Genocea Biosciences shares in the last 24 months for a total of $789,084.65 sold. More Insider Trading Tools from MarketBeat Related Companies: NBRV Insider Trading AHPI Insider Trading HGEN Insider Trading TCBP Insider Trading SQZ Insider Trading KRBP Insider Trading ELOX Insider Trading PALI Insider Trading FNCH Insider Trading SRNE Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale2 penny stocks insiders are buying This page (NASDAQ:GNCA) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Companytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.